We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cells.
Product News

Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025

Seer, Inc. (Nasdaq: SEER), announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025.
An RNA molecule.
Product News

Dovetail Genomics Announces Early Access Service for FFPE Sample Analysis, Enhancing Cancer Research Capabilities

Dovetail Genomics, announces the availability of its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis, offering new capabilities for detecting structural variants and profiling RNA in oncology research.
Someone with their hands outstretched, with a cartoon stomach hovering above.
Product News

Landmark Study at Homerton University Hospital Confirms GastroPanel®’s Diagnostic Accuracy

BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients.
Antibodies.
Product News

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement With LINDIS Biotech for the Commercial Supply of Catumaxomab

Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), announced the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech.
Cells.
Product News

Defined Hydrogel Enables Reproducible Culture of Cancer Cells in Xenograft Models

AMSBIO has launched MatriMix for PDX, a fully defined extracellular matrix (ECM) hydrogel comprising of collagen, laminin-511 E8 fragments and hyaluronic acid optimized to support patient-derived xenograft (PDX) studies.
A scientist pipetting into a test tube.
Product News

Geneoscopy Closes $105M in Series C Funding Round To Power Next-Generation of Gastrointestinal Diagnostic Tests

Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease.
Five students standing in front of a stand.
Product News

AMSBIO Invest in Future US Life Scientists

AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research Experience (CURE) program.
Breast cancer tissue.
Product News

Validated Tumor Tissue Samples for Cancer Research

CancerSeq™ FFPE tissues from AMSBIO are pre-screened tumor tissue samples for single nucleotide polymorphisms (SNP’s), insertions and deletions plus copy number variations (CNVs) using targeted Next Generation Sequencing to identify key mutations.
Cancer cells.
Product News

Bio-Rad Demonstrates Leadership Position in the Oncology Market at Association for Molecular Pathology 2024

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced updates on its oncology assay portfolio and regulatory milestones, ahead of its presence at the AMP 2024 meeting.
Cancer cells.
Product News

Transgene and ProBioGen Join Forces To Advance Individualized Cancer Vaccine Development

Transgene and ProBioGen, announce that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX® suspension cell line.
Advertisement